Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis

Journal of Neuroimmunology

Volumn 291, Issue , 2016, Pages 1-10

  Blair, Tiffany C ^a   Manoharan, Minsha ^a   Rawlings Rhea, Stephanie D ^a   Tagge, Ian ^a   Kohama, Steven G ^b   Hollister Smith, Julie ^b   Ferguson, Betsy ^b   Woltjer, Randall L ^a   Frederick, Meredith C ^a   Pollaro, James ^a   Rooney, William D ^a   Sherman, Larry S ^b   Bourdette, Dennis N ^a   Wong, Scott W ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Demyelination; Inflammatory; Interleukin 17 (IL 17); Intrathecal IgG; Magnetic resonance imaging (MRI); Th1; Th17

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 17; ACTIN BINDING PROTEIN; CYTOKINE; LEUKOCYTE ANTIGEN; MYELIN BASIC PROTEIN; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BIOTINYLATION; BRAIN MAPPING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATION; ENCEPHALOMYELITIS; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; MACACA FUSCATA; MALE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; ANIMAL; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; EMBRYOLOGY; IMMUNOLOGY; LYMPHOCYTE; MACACA; MACROPHAGE; METABOLISM; MICROGLIA; PATHOLOGY;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS; LYMPHOCYTES; MACACA; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MICROFILAMENT PROTEINS; MICROGLIA; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; NERVE TISSUE PROTEINS;

EID: 84959353630     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.11.026     Document Type: Article

References (45)

1. Axthelm M.K., Bourdette D.N., Marracci G.H., Su W., Mullaney E.T., Manoharan M., Kohama S.G., Pollaro J., Witkowski E., Wang P., Rooney W.D., Sherman L.S., Wong S.W. Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate. Ann. Neurol. 2011, 70:362-373.
2. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., Friese M., Schroder R., Deckert M., Schmidt S., Ravid R., Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000, 192:393-404.
3. Baeten D.L., Kuchroo V.K. How cytokine networks fuel inflammation: interleukin-17 and a tale of two autoimmune diseases. Nat. Med. 2013, 19:824-825.
4. Barnett M.H., Parratt J.D., Cho E.S., Prineas J.W. Immunoglobulins and complement in postmortem multiple sclerosis tissue. Ann. Neurol. 2009, 65:32-46.
5. Berer K., Wekerle H., Krishnamoorthy G. B cells in spontaneous autoimmune diseases of the central nervous system. Mol. Immunol. 2011, 48:1332-1337.
6. Bonnan M. Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments. Mult. Scler. Int. 2015, 2015:296184.
7. Breij E.C., Brink B.P., Veerhuis R., Van Den Berg C., Vloet R., Yan R., Dijkstra C.D., Van Der Valk P., Bo L. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 2008, 63:16-25.
8. Estep R.D., Hansen S.G., Rogers K.S., Axthelm M.K., Wong S.W. Genomic characterization of Japanese macaque rhadinovirus, a novel herpesvirus isolated from a nonhuman primate with a spontaneous inflammatory demyelinating disease. J. Virol. 2013, 87:512-523.
9. Fortini A.S., Sanders E.L., Weinshenker B.G., Katzmann J.A. Cerebrospinal fluid oligoclonal bands in the diagnosis of multiple sclerosis. Isoelectric focusing with IgG immunoblotting compared with high-resolution agarose gel electrophoresis and cerebrospinal fluid IgG index. Am. J. Clin. Pathol. 2003, 120:672-675.
10. Freedman M.S., Thompson E.J., Deisenhammer F., Giovannoni G., Grimsley G., Keir G., Ohman S., Racke M.K., Sharief M., Sindic C.J., Sellebjerg F., Tourtellotte W.W. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch. Neurol. 2005, 62:865-870.
11. Frischer J.M., Weigand S.D., Guo Y., Kale N., Parisi J.E., Pirko I., Mandrekar J., Bramow S., Metz I., Bruck W., Lassmann H., Lucchinetti C.F. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann. Neurol. 2015.
12. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9:393-407.
13. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H., Group H.T. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
14. Hedegaard C.J., Krakauer M., Bendtzen K., Lund H., Sellebjerg F., Nielsen C.H. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology 2008, 125:161-169.
15. Hellings N., Baree M., Verhoeven C., D'hooghe M.B., Medaer R., Bernard C.C., Raus J., Stinissen P. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J. Neurosci. Res. 2001, 63:290-302.
16. Hellings N., Gelin G., Medaer R., Bruckers L., Palmers Y., Raus J., Stinissen P. Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity. J. Neuroimmunol. 2002, 126:143-160.
17. International Multiple Sclerosis Genetics, C., Wellcome Trust Case Control, C., Sawcer S., Hellenthal G., Pirinen M., Spencer C.C., Patsopoulos N.A., Moutsianas L., Dilthey A., Su Z., Freeman C., Hunt S.E., Edkins S., Gray E., Booth D.R., Potter S.C., Goris A., Band G., Oturai A.B., Strange A., Saarela J., Bellenguez C., Fontaine B., Gillman M., Hemmer B., Gwilliam R., Zipp F., Jayakumar A., Martin R., Leslie S., Hawkins S., Giannoulatou E., D'alfonso S., Blackburn H., Martinelli Boneschi F., Liddle J., Harbo H.F., Perez M.L., Spurkland A., Waller M.J., Mycko M.P., Ricketts M., Comabella M., Hammond N., Kockum I., Mccann O.T., Ban M., Whittaker P., Kemppinen A., Weston P., Hawkins C., Widaa S., Zajicek J., Dronov S., Robertson N., Bumpstead S.J., Barcellos L.F., Ravindrarajah R., Abraham R., Alfredsson L., Ardlie K., Aubin C., Baker A., Baker K., Baranzini S.E., Bergamaschi L., Bergamaschi R., Bernstein A., Berthele A., Boggild M., Bradfield J.P., Brassat D., Broadley S.A., Buck D., Butzkueven H., Capra R., Carroll W.M., Cavalla P., Celius E.G., Cepok S., Chiavacci R., Clerget-Darpoux F., Clysters K., Comi G., Cossburn M., Cournu-Rebeix I., Cox M.B., Cozen W., Cree B.A., Cross A.H., Cusi D., Daly M.J., Davis E., De Bakker P.I., Debouverie M., D'hooghe M.B., Dixon K., Dobosi R., Dubois B., Ellinghaus D., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
18. Ishizu T., Minohara M., Ichiyama T., Kira R., Tanaka M., Osoegawa M., Hara T., Furukawa S., Kira J.-I. CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J. Neuroimmunol. 2006, 175:52-58.
19. Jadidi-Niaragh F., Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand. J. Immunol. 2011, 74:1-13.
20. Jager A., Dardalhon V., Sobel R.A., Bettelli E., Kuchroo V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 2009, 183:7169-7177.
21. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13:1173-1175.
22. Kebir H., Ifergan I., Alvarez J.I., Bernard M., Poirier J., Arbour N., Duquette P., Prat A. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 2009, 66:390-402.
23. Kerlero De Rosbo N., Milo R., Lees M.B., Burger D., Bernard C.C., Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 1993, 92:2602-2608.
24. Link H., Huang Y.M. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J. Neuroimmunol. 2006, 180:17-28.
25. Link H., Tibbling G. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand. J. Clin. Lab. Invest. 1977, 37:391-396.
26. Lovett-Racke A.E., Yang Y., Racke M.K. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?. Biochim. Biophys. Acta 2011, 1812:246-251.
27. Magliozzi R., Howell O.W., Reeves C., Roncaroli F., Nicholas R., Serafini B., Aloisi F., Reynolds R. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann. Neurol. 2010, 68:477-493.
28. Montes M., Zhang X., Berthelot L., Laplaud D.A., Brouard S., Jin J., Rogan S., Armao D., Jewells V., Soulillou J.P., Markovic-Plese S. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin. Immunol. 2009, 130:133-144.
29. Parrish J.B., Yeh E.A. Acuted disseminated encephalomyelitis. Adv. Exp. Med. Biol. 2012, 724:1-14.
30. Petzold A. Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J. Neuroimmunol. 2013, 262:1-10.
31. Pierson E., Simmons S.B., Castelli L., Goverman J.M. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 2012, 248:205-215.
32. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F.D., Montalban X., O'connor P., Sandberg-Wollheim M., Thompson A.J., Waubant E., Weinshenker B., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
33. Popescu B.F., Lucchinetti C.F. Pathology of demyelinating diseases. Annu. Rev. Pathol. 2012, 7:185-217.
34. Probstel A.K., Sanderson N.S., Derfuss T. B cells and autoantibodies in multiple sclerosis. Int. J. Mol. Sci. 2015, 16:16576-16592.
35. Procaccini C., De Rosa V., Pucino V., Formisano L., Matarese G. Animal models of multiple sclerosis. Eur. J. Pharmacol. 2015, 759:182-191.
36. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14:164-174.
37. Singh S., Metz I., Amor S., Van Der Valk P., Stadelmann C., Bruck W. Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol. 2013, 125:595-608.
38. Slywester A.W., Hansen S.G., Picker L.J. Quantitation of T Cell Antigen-Specific Memory Responses in Rhesus Macaques, Using Cytokine Flow Cytometry (CFC, Also Known as ICS and ICCS): from Assay set-up to Data Acquisition. Bio-Protocol.org 2014, (April 20). 2014 ed.
39. Steiner I. On human disease and animal models. Ann. Neurol. 2011, 70:343-344.
40. Steiner I., Kennedy P.G. Acute disseminated encephalomyelitis: current knowledge and open questions. J. Neurovirol. 2015.
41. Trip S.A., Miller D.H. Imaging in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2005, 76(Suppl. 3):iii11-iii18.
42. Tumani H., Deisenhammer F., Giovannoni G., Gold R., Hartung H.P., Hemmer B., Hohlfeld R., Otto M., Stangel M., Wildemann B., Zettl U.K. Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis. Ann. Neurol. 2011, 70:520. (author reply 521).
43. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008, 172:146-155.
44. Waisman A., Hauptmann J., Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol. 2015, 129:625-637.
45. Wingerchuk D.M., Lucchinetti C.F. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr. Opin. Neurol. 2007, 20:343-350.